The results showed that compared with the control group, there were only six genes (CD2, CD8A, GNLY, IFI44, NKG7, and OAS2) with statistically significant differences in expression in the UC and NASH validated datasets (Fig. 5a, b). The gene discussed is OAS2; the disease is metabolic dysfunction-associated steatohepatitis.